Workflow Automation of New Cell-Based Therapies
Engineering-driven life science automation company wanted to develop solutions for the emerging cell-therapy market. Would the market be large enough to build a business?
Significant investment into the cell-therapy market over the last decade. Will investment translate into commercial opportunities? If the addressable market is sufficiently large, what are the specific opportunities for investment available to the company?
In-depth interviews with industry experts to understand the potential uses of automation in the cold chain to address unmet needs and bottlenecks
Bottoms-up model development and forecasts for market sizing and growth
End-to-end workflows indicated the location of the greatest need for automation in the cold chain
Provided market opportunity assessment based on addressable needs
Created a partnership and acquisition roadmap for the next
Company invested/partnered in areas CBA identified as greatest opportunity and exceeded original plan over the last 3 years